Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 4:15 PM View:  | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 10-Sep-24 | Sale | 3,219 | $8.12 | $26,138.30 | (2%) 198.91K to 195.69K | |
| 21-Jun-24 6:38 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 20-Jun-24 | Sale | 18,241 | $8.11 | $147,934.00 | (8%) 217.15K to 198.91K | |
| 21-Jun-24 6:39 PM View: | Campobasso Matthew General Counsel | Enfusion, Inc. (ENFN) | 18-Jun-24 | Sale | 1,651 | $8.17 | $13,488.70 | (3%) 55.95K to 54.3K | |
| 21-Jun-24 6:40 PM View: | Gutowski Valeria Chief Accounting Officer | Enfusion, Inc. (ENFN) | 18-Jun-24 | Sale | 1,258 | $8.17 | $10,277.90 | (3%) 36.86K to 35.6K | |
| 21-Jun-24 6:38 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 18-Jun-24 | Sale | 10,539 | $8.17 | $86,103.60 | (5%) 227.69K to 217.15K | |
| 17-Jun-24 9:14 PM View: | Somers Deirdre Director | Enfusion, Inc. (ENFN) | 14-Jun-24 | Sale | 4,629 | $8.40 | $38,883.60 | (10%) 47.94K to 43.31K | |
| 17-Jun-24 9:12 PM View: | Spellacy Michael Director | Enfusion, Inc. (ENFN) | 13-Jun-24 | Grant | 13,470 | -- | -- | 31% 43.34K to 56.81K | |
| 17-Jun-24 9:10 PM View: | Derose Kathleen Director | Enfusion, Inc. (ENFN) | 13-Jun-24 | Grant | 13,470 | -- | -- | 29% 47.25K to 60.72K | |
| 17-Jun-24 9:08 PM View: | Leibowitz Lawrence E Director | Enfusion, Inc. (ENFN) | 13-Jun-24 | Grant | 13,470 | -- | -- | 8% 162.1K to 175.57K | |
| 17-Jun-24 9:11 PM View: | Hauser Jan Director | Enfusion, Inc. (ENFN) | 13-Jun-24 | Grant | 13,470 | -- | -- | 30% 44.45K to 57.92K | |
| 17-Jun-24 9:14 PM View: | Somers Deirdre Director | Enfusion, Inc. (ENFN) | 13-Jun-24 | Grant | 13,470 | -- | -- | 39% 34.47K to 47.94K | |
| 22-May-24 3:36 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 20-May-24 | Sale | 34,059 | $9.55 | $325,263.00 | (13%) 261.75K to 227.69K | |
| 07-Mar-24 5:15 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 05-Mar-24 | Grant | 249,701 | -- | -- | 17% 1.43M to 1.68M | |
| 05-Mar-24 8:20 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Grant | 109,812 | $0.41 | $45,162.00 | 71% 153.85K to 263.66K | |
| 05-Mar-24 8:26 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 01-Mar-24 | Payment of Exercise | 4,069 | $8.67 | $35,278.20 | (< 1%) 1.44M to 1.43M | |
| 05-Mar-24 8:20 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Payment of Exercise | 1,906 | $8.67 | $16,525.00 | (< 1%) 263.66K to 261.75K | |
| 05-Mar-24 8:21 PM View: | Campobasso Matthew General Counsel | Enfusion, Inc. (ENFN) | 01-Mar-24 | Grant | 26,193 | $1.03 | $27,085.10 | 85% 30.84K to 57.03K | |
| 05-Mar-24 8:23 PM View: | Herring Bradley Chief Financial Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Grant | 85,671 | $0.97 | $82,763.80 | 40% 211.6K to 297.27K | |
| 05-Mar-24 8:24 PM View: | Gutowski Valeria Chief Accounting Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Grant | 20,338 | $1.29 | $26,322.10 | 116% 17.57K to 37.91K | |
| 05-Mar-24 8:26 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 01-Mar-24 | Grant | 13,887 | $8.67 | $120,400.00 | < 1% 1.42M to 1.44M | |
| 05-Mar-24 8:25 PM View: | Pawar Neal Chief Operating Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Grant | 144,176 | -- | -- | 14% 1.04M to 1.18M | |
| 05-Mar-24 8:21 PM View: | Campobasso Matthew General Counsel | Enfusion, Inc. (ENFN) | 01-Mar-24 | Payment of Exercise | 1,081 | $8.67 | $9,372.27 | (2%) 57.03K to 55.95K | |
| 05-Mar-24 8:23 PM View: | Herring Bradley Chief Financial Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Payment of Exercise | 2,325 | $8.67 | $20,157.80 | (< 1%) 297.27K to 294.95K | |
| 05-Mar-24 8:24 PM View: | Gutowski Valeria Chief Accounting Officer | Enfusion, Inc. (ENFN) | 01-Mar-24 | Payment of Exercise | 1,051 | $8.67 | $9,112.17 | (3%) 37.91K to 36.86K | |
| 04-Mar-24 7:32 PM View: | Gutowski Valeria Chief Accounting Officer | Enfusion, Inc. (ENFN) | 29-Feb-24 | Sale | 27 | $8.73 | $235.71 | (< 1%) 17.6K to 17.57K | |
| 04-Mar-24 7:35 PM View: | Campobasso Matthew General Counsel | Enfusion, Inc. (ENFN) | 29-Feb-24 | Sale | 108 | $8.73 | $942.84 | (< 1%) 30.95K to 30.84K | |
| 12-Jan-24 7:00 PM View: | Somers Deirdre Director | Enfusion, Inc. (ENFN) | 10-Jan-24 | Sale | 1,770 | $8.65 | $15,310.50 | (5%) 36.24K to 34.47K | |
| 10-Jan-24 8:00 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 09-Jan-24 | Sale | 410 | $8.95 | $3,669.50 | (< 1%) 154.26K to 153.85K | |
| 10-Jan-24 8:02 PM View: | Campobasso Matthew General Counsel | Enfusion, Inc. (ENFN) | 09-Jan-24 | Sale | 493 | $8.95 | $4,412.35 | (2%) 31.44K to 30.95K | |
| 10-Jan-24 8:01 PM View: | Herring Bradley Chief Financial Officer | Enfusion, Inc. (ENFN) | 09-Jan-24 | Sale | 2,090 | $8.95 | $18,705.50 | (< 1%) 213.69K to 211.6K | |
| 10-Jan-24 8:02 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 09-Jan-24 | Sale | 1,355 | $8.95 | $12,127.20 | (< 1%) 1.42M to 1.42M | |
| 10-Jan-24 8:02 PM View: | Campobasso Matthew General Counsel | Enfusion, Inc. (ENFN) | 08-Jan-24 | Sale | 472 | $9.23 | $4,356.56 | (1%) 31.91K to 31.44K | |
| 10-Jan-24 8:01 PM View: | Herring Bradley Chief Financial Officer | Enfusion, Inc. (ENFN) | 08-Jan-24 | Sale | 1,998 | $9.23 | $18,441.50 | (< 1%) 215.69K to 213.69K | |
| 10-Jan-24 8:02 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 08-Jan-24 | Sale | 1,295 | $9.23 | $11,952.80 | (< 1%) 1.42M to 1.42M | |
| 10-Jan-24 8:00 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 08-Jan-24 | Sale | 391 | $9.23 | $3,608.93 | (< 1%) 154.65K to 154.26K | |
| 18-Dec-23 7:00 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 14-Dec-23 | Sale | 100,000 | $10.01 | $1,001,000.00 | (7%) 1.52M to 1.42M | |
| 05-Dec-23 7:00 PM View: | Movchan Oleg Chief Executive Officer Director 10% Owner | Enfusion, Inc. (ENFN) | 01-Dec-23 | Sale | 150,000 | $10.09 | $1,513,500.00 | (9%) 1.67M to 1.52M | |
| 28-Nov-23 6:00 PM View: | Malherbe Stephen 10% Owner | Enfusion, Inc. (ENFN) | 27-Nov-23 | Sale | 1,000,000 | $9.86 | $9,860,000.00 | (100%) 1000.0K to 0 | |
| 29-Nov-23 7:04 PM View: | Pawar Neal Chief Operating Officer | Enfusion, Inc. (ENFN) | 27-Nov-23 | Payment of Exercise | 25,273 | $9.89 | $249,950.00 | (2%) 1.07M to 1.04M | |
| 29-Nov-23 7:04 PM View: | Pawar Neal Chief Operating Officer | Enfusion, Inc. (ENFN) | 27-Nov-23 | Grant | 1,065,670 | -- | -- | 100% 0 to 1.07M | |
| 16-Nov-23 8:30 PM View: | Groman Dan Chief Technology Officer | Enfusion, Inc. (ENFN) | 14-Nov-23 | Sale (Planned) | 5,000 | $9.97 | $49,850.00 | (4%) 138.83K to 133.83K | |
| 19-Oct-23 4:15 PM View: | Groman Dan Chief Technology Officer | Enfusion, Inc. (ENFN) | 17-Oct-23 | Sale (Planned) | 5,000 | $9.09 | $45,450.00 | (3%) 143.83K to 138.83K | |
| 21-Sep-23 4:15 PM View: | Groman Dan Chief Technology Officer | Enfusion, Inc. (ENFN) | 19-Sep-23 | Sale (Planned) | 5,000 | $9.07 | $45,350.00 | (3%) 148.83K to 143.83K | |
| 13-Sep-23 4:15 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 11-Sep-23 | Payment of Exercise | 3,182 | $8.82 | $28,065.20 | (2%) 157.83K to 154.65K | |
| 18-Aug-23 4:16 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 17-Aug-23 | Grant | 558 | -- | -- | < 1% 157.46K to 158.02K | |
| 18-Aug-23 4:16 PM View: | Bastone Bronwen Chief People Officer | Enfusion, Inc. (ENFN) | 17-Aug-23 | Payment of Exercise | 189 | $8.18 | $1,546.02 | (< 1%) 158.02K to 157.83K | |
| 18-Aug-23 4:16 PM View: | Groman Dan Chief Technology Officer | Enfusion, Inc. (ENFN) | 17-Aug-23 | Payment of Exercise | 8,065 | $8.18 | $65,971.70 | (5%) 156.89K to 148.83K | |
| 18-Aug-23 4:15 PM View: | Leibowitz Lawrence E Director | Enfusion, Inc. (ENFN) | 17-Aug-23 | Grant | 6,335 | -- | -- | 4% 155.77K to 162.1K | |
| 18-Aug-23 4:16 PM View: | Groman Dan Chief Technology Officer | Enfusion, Inc. (ENFN) | 17-Aug-23 | Grant | 19,223 | -- | -- | 14% 137.67K to 156.89K | |
| 18-Aug-23 4:16 PM View: | Groman Dan Chief Technology Officer | Enfusion, Inc. (ENFN) | 16-Aug-23 | Grant | 31,444 | -- | -- | 26% 119.42K to 150.86K |
